In News:

India will host the AI Impact Summit 2026, marking the first time a major global AI governance forum is being held in the Global South. The summit represents a significant shift in the international discourse on artificial intelligence,  from narrow concerns of safety and regulation to broader questions of development, equity, and long-term societal impact.

Evolution of Global AI Governance Forums

The New Delhi summit builds upon a sequence of international engagements on AI governance. The Bletchley Park AI Safety Summit (2023) primarily focused on identifying catastrophic AI risks and resulted in the Bletchley Declaration. The Seoul Summit (2024) expanded the agenda to include innovation and inclusivity, while the Paris AI Action Summit (2025) shifted attention towards implementation and economic opportunities. Each phase has progressively widened the scope from risk containment to practical deployment. India’s summit seeks to carry this evolution forward by anchoring AI governance in developmental priorities.

India’s Distinctive Vision

Unlike earlier summits dominated by regulatory anxieties of advanced economies, India is framing the conversation around “People, Planet, and Progress.” The focus is on deploying AI solutions to address real-world challenges such as employment transitions, sustainability, and service delivery—especially in developing countries. This approach reflects India’s dual identity: an emerging AI power and a representative voice of the Global South seeking a more equitable share in the global AI value chain.

Scale, Participation and Agenda

Described by Union IT Minister Ashwini Vaishnaw as the largest such gathering so far, the summit is expected to witness participation from over 100 countries, including 15–20 heads of government, 50+ ministers, and 40+ CEOs of leading global and Indian technology firms. Narendra Modi will inaugurate the event and engage with global industry leaders through a CEO roundtable.

The summit will follow a multi-stakeholder format, bringing together governments, industry, researchers, civil society, and international institutions. Working groups will deliberate on AI’s impact on jobs, trust and safety frameworks, and sector-specific applications across healthcare, industry, and governance.

India’s Domestic AI Push

A key feature of the summit will be the launch of indigenous AI language models under the IndiaAI Mission (?10,370 crore), including both foundational and small language models. The event will also showcase over 500 AI startups and host around 500 parallel sessions, underscoring India’s ambition to emerge as a global AI innovation hub.

Geopolitics and China’s Participation

India has extended an invitation to China, signalling a pragmatic approach to AI governance despite geopolitical sensitivities. China’s participation follows precedents set at earlier summits and coincides with signs of easing bilateral tensions, such as the resumption of direct flights and partial relaxation of rare-earth export restrictions affecting Indian manufacturers. The summit’s non-binding, host-driven format allows India strategic flexibility in shaping participation.

Structural Constraints: Hardware and Energy

Despite its ambitions, India faces critical constraints. The absence of domestically manufactured advanced computing hardware, particularly GPUs, limits AI self-reliance. Prospective gains from an interim India–US tech trade deal and tax holidays for data centres aim to mitigate this gap. Energy requirements pose another challenge, with the government exploring nuclear power as a long-term solution for energy-intensive AI data centres.

Conclusion

The AI Impact Summit 2026 represents India’s attempt to redefine global AI governance through a development-first lens. By aligning technology with inclusivity, sustainability, and economic opportunity, India seeks not only a larger share of the AI pie but also a more representative and balanced global AI order, one that reflects the aspirations and constraints of the developing world.

In News:

The Genome India Project is an ambitious national initiative aimed at decoding the genetic diversity of India’s population. Launched in January 2020 by the Department of Biotechnology (DBT), the project seeks to create a comprehensive map of India’s genetic variations, offering insights that can revolutionize public health, medicine, and our understanding of human genetics.

What is Genome Sequencing?

Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome. The human genome, composed of about 3 billion base pairs of DNA, contains all the genetic instructions necessary for the growth, development, and functioning of the human body. The process involves extracting DNA from a sample (often blood), breaking it into smaller fragments, and using a sequencer to decode these fragments. The data is then reassembled to reconstruct the full genome.

Key Aims and Objectives

The Genome India Project aims to address several crucial scientific and healthcare challenges:

• Create an Exhaustive Catalog of Genetic Variations: This includes common, low-frequency, rare, and structural variations (such as Single Nucleotide Polymorphisms or SNPs).
• Establish a Reference Haplotype Structure: This reference panel will be used for imputing missing genetic variations in future genetic studies.
• Design Affordable Genome-wide Arrays: These arrays will be useful for research and diagnostics at a lower cost, making genetic analysis accessible.
• Create a Biobank for Future Research: The collected DNA and plasma will be preserved for future studies to facilitate ongoing genetic research.

Genome India Project: Phase 1 and Key Findings

The project’s Phase 1 focused on sequencing the genomes of 10,074 individuals from 99 ethnic groups across India. This initiative provides a critical baseline for studying the country’s genetic diversity. Some of the key findings include:

• 459 plant species have been identified as part of genetic diversity studies.
• 135 million genetic variations have been uncovered, including 7 million that are unique to India, not found in global databases.
• The project has revealed several genetic risks specific to Indian populations, such as the MYBPC3 mutation (linked to cardiac arrest) and the LAMB3 mutation (associated with a lethal skin condition), which are not commonly seen in global datasets.

This database will serve as a vital resource for researchers, contributing to the development of precision medicine, better disease diagnosis, and more personalized treatments.

Second Phase: Expanding the Scope

The second phase of the Genome India Project will focus on sequencing the genomes of individuals suffering from specific diseases. This will enable researchers to:

• Compare the genomes of healthy individuals with those having diseases, helping identify genetic mutations responsible for conditions like cancer, diabetes, and neurodegenerative diseases.
• Investigate rare diseases specific to Indian populations and develop therapies tailored to these conditions.

By sequencing the genomes of individuals with various conditions, the project aims to pinpoint genetic factors that contribute to the pre-disposition or causation of diseases.

Data Sharing and Security

To ensure data security and privacy, the genetic information will be made available only through managed access. Researchers interested in using the data will need to submit a proposal and collaborate with the Department of Biotechnology. The data will be stored securely at the Indian Biological Data Centre (IBDC) in Faridabad, Haryana, and anonymized to maintain confidentiality.

Why Does India Need Its Own Genetic Database?

India is home to a highly diverse population, with over 4,600 distinct ethnic groups and varying genetic backgrounds. The country’s genetic diversity, shaped by its geographical, cultural, and historical context, cannot be fully understood through datasets derived from other countries. The Genome India Project helps:

• Identify Genetic Risk Factors: For various diseases, paving the way for developing targeted diagnostic tools and therapies.
• Uncover Unique Variants: Some genetic mutations found in India, such as the Vaishya community’s resistance to anaesthetics, are absent in global databases.
• Address Population-specific Health Issues: Genetic mapping enables the identification of prevalent diseases and health conditions specific to Indian populations.

Global Context and Comparison

India’s genome sequencing effort is part of a larger global movement in genomics:

• Human Genome Project (2003): The first international effort to decode the human genome.
• 1,000 Genome Project (2012): Published 1,092 human genome sequences.
• UK 100,000 Genome Project (2018): Sequenced 100,000 genomes for health research.
• European Genome Project: Aims to sequence over 1 million genomes across 24 countries.

The Genome India Project fills a crucial gap by focusing on the genetic diversity of Indian populations, which differs significantly from the genetic profiles studied in Western or European genomes.

Applications of Genome India Project

The Genome India Project has the potential to impact multiple areas:

• Advancements in Medicine: Understanding genetic variations can lead to the development of personalized medicine, where treatments are tailored to individual genetic profiles.
• Genetic and Infectious Disease Control: The project helps identify genetic resistance to diseases, and aids in understanding how certain populations may respond differently to drugs or vaccines.
• Public Health Policies: Data from the project can inform health policies, especially in tackling diseases prevalent in specific regions or communities.
• International Research Collaboration: The project aims to foster collaboration with global research communities, enhancing India’s presence in the field of genomics.

Conclusion:

The Genome India Project is a landmark initiative for India’s scientific community, enabling better understanding of the country’s genetic diversity and paving the way for breakthroughs in medicine, healthcare, and disease prevention. The ability to analyze genetic variations on such a large scale provides immense opportunities for precision medicine and personalized treatments.